Skip to main content
SpringerLink
Log in

Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Prediction of poor patient outcome as a effect of adjuvant therapy in stage II colorectal cancer (CRC) remains a matter of controversy. Tumor expression of CD10 and CD15 is reportedly related to poor outcome in CRC. In this study, we investigated whether the expression of CD10 and CD15 is a predictor of outcome and the effect of adjuvant therapy in stage II CRC.

Materials and methods

Immunohistochemical analyses for CD10 and CD15 and some additional markers (CD11b, CD14, CD163, CD3, and CD20) were performed using paraffin sections of CRC specimens from 57 patients who had undergone curative surgical treatments between 1998 and 2004. Forty of these patients received postoperative adjuvant therapy. We distinguished between expression in tumor cells (tCD10 and tCD15), in stromal cells (sCD10), and infiltrating immune cells (iCD10 and iCD15).

Results

Expression of iCD10 was observed in 21.1% (12/57) of the specimens examined. Of all expression patterns, only iCD10 expression at the cancer invasion front was a useful predictor of a disease-free period and overall survival in stage II CRC. Adjuvant therapy improved the outcome of iCD10+ patients. CD10+ immune cells were heterogeneous in origin and partially overlapped the cells positive for myeloid lineage markers, including CD11b and CD15.

Conclusions

iCD10 expression at the tumor invasion front is a useful marker for predicting a high risk of recurrence and mortality in stage II CRCs. CD10+ immune cells appear to be of myeloid origin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96

    Article  PubMed  Google Scholar 

  2. Greene FL, Stewart AK, Norton HJ (2002) A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 236(4):416–421

    Article  PubMed  Google Scholar 

  3. Lin CC, Lin JK, Chang SC et al (2009) Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute. Int J Colorectal Dis 24(6):665–676

    Article  PubMed  Google Scholar 

  4. Köhne CH (2006) Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Against the proposal. Lancet Oncol 7(6):516–517

    PubMed  Google Scholar 

  5. Sobrero A (2006) Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposal. Lancet Oncol 7(6):515–516

    Article  PubMed  Google Scholar 

  6. Greaves MF, Hariri G, Newman RA et al (1983) Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood 61:628–639

    PubMed  CAS  Google Scholar 

  7. McIntosh GG, Lodge AJ, Watson P et al (1999) NCL-CD10–270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 154(1):77–82

    Article  PubMed  CAS  Google Scholar 

  8. Yasuda M, Itoh J, Satoh Y et al (2005) Availability of CD10 as a histopathological diagnostic marker. Acta Histochem Cytochem 38(1):17–24

    Article  Google Scholar 

  9. Fujimoto Y, Nakanishi Y, Sekine S et al (2005) CD10 expression in colorectal carcinoma correlates with liver metastasis. Dis Colon Rectum 48(10):1883–1889

    Article  PubMed  Google Scholar 

  10. Yao T, Tsutsumi S, Akaiwa Y et al (2001) Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res 92:755–761

    Article  PubMed  CAS  Google Scholar 

  11. Huang WB, Zhou XJ, Chen JY et al (2005) CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis. Jpn J Clin Oncol 35(5):245–250

    Article  PubMed  Google Scholar 

  12. Ogawa H, Iwaya K, Izumi M et al (2002) Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 33(8):806–811

    Article  PubMed  Google Scholar 

  13. Nakamori S, Kameyama M, Imaoka S et al (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53(15):3632–3637

    PubMed  CAS  Google Scholar 

  14. Nakamori S, Kameyama M, Imaoka S et al (1997) Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis. Dis Colon Rectum 40(4):420–431

    Article  PubMed  CAS  Google Scholar 

  15. Ohji Y, Yao T, Eguchi T et al (2007) Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep 17(3):525–530

    PubMed  CAS  Google Scholar 

  16. Sato Y, Itoh F, Hinoda Y et al (1996) Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon. J Gastroenterol 31(1):12–17

    Article  PubMed  CAS  Google Scholar 

  17. Connelly JC, Chambless R, Holiday D et al (1993) Up-regulation of neutral endopeptidase (CALLA) in human neutrophils by granulocyte-macrophage colony-stimulating factor. J Leukoc Biol 53(6):685–690

    PubMed  CAS  Google Scholar 

  18. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867

    Article  PubMed  CAS  Google Scholar 

  19. Lin EY, Pollard JW (2004) Role of infiltrated leucocytes in tumor growth and spread. Br J Cancer 90(11):2053–2058

    Article  PubMed  CAS  Google Scholar 

  20. Arias JI, Aller MA, Arias J (2007) Cancer cell: using inflammation to invade the host. Mol Cancer 6:29

    Article  PubMed  Google Scholar 

  21. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454(7203):436–444

    Article  PubMed  CAS  Google Scholar 

  22. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J et al (2000) Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer 88(7):1544–1548

    Article  PubMed  CAS  Google Scholar 

  23. Klintrup K, Mäkinen JM, Kauppila S et al (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer 41(17):2645–2654

    Article  PubMed  Google Scholar 

  24. Serafini P, Borrello I, Bronte V (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16(1):53–65

    Article  PubMed  CAS  Google Scholar 

  25. Ostrand-Rosenberg S, Sinha P (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182(8):4499–4506

    Article  PubMed  CAS  Google Scholar 

  26. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162–174

    Article  PubMed  CAS  Google Scholar 

  27. Shojaei F, Zhong C, Wu X et al (2008) Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 18(8):372–378

    Article  PubMed  CAS  Google Scholar 

  28. Murdoch C, Muthana M, Coffelt SB et al (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8(8):618–631

    Article  PubMed  CAS  Google Scholar 

  29. Zumsteg A, Baeriswyl V, Imaizumi N et al (2009) Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 4(9):e7067

    Article  PubMed  Google Scholar 

  30. Hall PA, D’Ardenne AJ (1987) Value of CD15 immunostaining in diagnosing Hodgkin’s disease: a review of the published literature. J Clin Pathol 40:1298–1304

    Article  PubMed  CAS  Google Scholar 

  31. Fujita S, Taniguchi H, Yao T et al (2010) Multi-institutional study of risk factors of liver metastasis from colorectal cancer: correlation with CD10 expression. Int J Colorectal Dis 25(6):681–686

    Article  PubMed  Google Scholar 

  32. Braun MP, Martin PJ, Ledbetter JA et al (1983) Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens. Blood 61(4):718–725

    PubMed  CAS  Google Scholar 

  33. Demirci U, Coskun U, Sancak B et al (2009) Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma? Asian Pac J Cancer Prev 10(6):1021–1024

    PubMed  Google Scholar 

Download references

Conflict of interest

No author has any conflict of interest.

Author information

Authors and Affiliations

  1. First Department of Surgery, Shiga University of Medical Science, Seta-tsukinowa-cho, Otsu, Shiga, 520-2192, Japan

    Do Trong Khanh, Eiji Mekata, Tomoharu Shimizu, Takeshi Tatsuta, Yoshihiro Endo, Yoshimasa Kurumi & Tohru Tani

  2. First Department of Pathology, Shiga University of Medical Science, Otsu, Japan

    Ken-ichi Mukaisho & Hiroyuki Sugihara

Authors
  1. Do Trong Khanh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eiji Mekata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ken-ichi Mukaisho
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomoharu Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takeshi Tatsuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroyuki Sugihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshihiro Endo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshimasa Kurumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tohru Tani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eiji Mekata.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 88 kb)

About this article

Cite this article

Khanh, D.T., Mekata, E., Mukaisho, Ki. et al. Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer. Int J Clin Oncol 17, 240–249 (2012). https://doi.org/10.1007/s10147-011-0281-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-011-0281-8

Keywords

Search

Navigation